product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Mouse anti Human Complement Factor H
catalog :
MCA508G
quantity :
0.2 mg
price :
372 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
OX-23
reactivity :
human, mouse
application :
western blot, ELISA, immunoprecipitation
more info or order :
citations: 1
Published Application/Species/Sample/DilutionReference
  • ELISA; mouse; fig 5
  • ELISA; human; 1:250; fig 5
Daniels Treffandier H, de Nie K, Marsay L, Dold C, Sadarangani M, Reyes Sandoval A, et al. Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles. PLoS ONE. 2016;11:e0148840 pubmed publisher
image
image 1 :
Bio-Rad MCA508G image 1
Published customer image: . Mouse anti Human factor H antibody, clone OX-23 ( MCA508G ) used as a capture reagent in a sandwich ELISA for HfH levels in murine sera with Sheep anti Human complement factor H antibody ( 4400-9504 ) as a detection reagent . Image caption: . Effect of the presence of hfH in mice on the nOMV immunogenicity. A. Evolution of hfH concentration in mouse serum over time after two IP injection of 0.5mg purified hfH (black arrows) 24 and 0.5 hours prior to immunization (grey arrow). B. Serum Bactericidal Assay (SBA) titers against 44/76-SL wild-type in pooled sera from C57bl/6 mice pre-injected with 800 μg/ml hfH or hSA, 14 days following immunization with 5 &mu:g of nOMV lpxl1 or nOMV dis . C. Individual SBA titers against 44/76-SL, dots represent individual animals D. Individual ELISA titers against rfHbp induced after one dose of H44/76 Lpxl1 OMV in mice pre-injected with hfH or hSA, *p = 0.016, not all sera were available. C, D dots represent individual animals, the geometric mean and 95% confidence interval are represented as horizontal bars. From: Daniels-Treffandier H, de Nie K, Marsay L, Dold C, Sadarangani M, Reyes-Sandoval A, et al . (2016). Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles. PLoS ONE 11(2): e0148840 .
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
ProductCode :
MCA508G
Description :
Mouse anti Human Complement Factor H
Specificity :
Complement Factor H
TargetSpecies :
Human
Host :
Mouse
Format :
Purified
Isotypes :
IgG1
Applications :
WB,IP,E,R
ApplicationTypes :
Western Blotting,Immunoprecipitation,ELISA,Radioimmunoassays
Cross Reactivities :
Sheep,Rabbit,Bovine,Chicken,Primate,Pig,Mouse
Clone :
OX-23
Quantity :
0.2 mg
Quantity Value :
0.2
Quantity Type :
mg
Uniprot Accessions :
P08603
Gene :
CFH
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3075
Published Synonyms :
H Factor 1
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1.0 mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
266
PriceEUR :
372
PriceUSD :
372 USD
PriceCHF :
405
PriceSEK :
4055
PriceNOK :
4075
PriceDKK :
2774
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.